Showing results (91-100 of 189) with videos related to

Sort By:
Pageof 19
Arthritis & Rheumatology (Hoboken, N.J.)|April 29, 2021
What Does It Mean to Be a British Isles Lupus Assessment Group-Based Composite Lupus Assessment Responder? Post Hoc Analysis of Two Phase III TrialsRichard Furie, Eric F Morand, Ian N Bruce, et al.
British Journal of Clinical Pharmacology|October 31, 2019
A novel approach to support implementation of biosimilars within a UK tertiary hospitalKatherine Saxby, Sonali Sanghvi, Pritesh N Bodalia, et al.
Arthritis Research & Therapy|April 19, 2015
Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assaysBahar Artim-Esen, Charis Pericleous, Ian Mackie, et al.
British Journal of Clinical Pharmacology|July 21, 2023
Effectiveness of biosimilar adoption within a UK tertiary hospital: 6-year follow-upAndrew Barron, Jennifer Chung, Robin E Ferner, et al.
Frontiers in Pharmacology|February 19, 2021
Biomarkers of Response to Biologic Therapy in Juvenile Idiopathic ArthritisVarvara Choida, Margaret Hall-Craggs, Bethany R Jebson, et al.
The Journal of Rheumatology|March 1, 2003
Defining Clinical Improvement in Adult and Juvenile MyositisLisa G Rider, Edward H Giannini, Michael Harris-Love, et al.
Kidney International Reports|January 16, 2026
Characterizing the NIH Activity and Chronicity Indices in 2 Independent Lupus Nephritis CohortsValentina Querin, Natasha Jordan, David P D'Cruz, et al.
Pageof 19